Finotti P, Pagetta A
Department of Pharmacology, University of Padova, Italy.
Clin Chim Acta. 1997 Aug 29;264(2):133-48. doi: 10.1016/s0009-8981(97)00090-9.
A partially purified preparation of human alpha 1-antitrypsin (alpha 1-AT) shown to be 60% active as an inhibitor of bovine trypsin, was chosen as starting material to investigate the nature and extent of contamination by human serum albumin (HSA) and to see whether or not such a contamination was responsible for both the reduced inhibitory activity and the slower migratory rate of the proteinase inhibitor in SDS-PAGE. Immunoblotting analysis revealed the presence of HSA in the unprocessed preparation of alpha 1-AT which, both in denaturing and non-denaturing PAGEs, had the same mobility as HSA, appearing as a single band of 65 kDa. By submitting the unprocessed alpha 1-AT preparation to affinity chromatography on an Affi-Gel Blue chromatography column, an apparently highly purified and homogeneous form of alpha 1-AT was obtained, as confirmed by measurement of inhibitory activity and densitometric scanning of SDS-PAGE in non-reducing conditions. However, immunoblotting analysis still revealed the presence of HSA in the most active fractions of the inhibitor eluted from the column, and regardless of purification degree, the molecular mass of the inhibitor was always 65 kDa. Treatment with beta-mercaptoethanol led to separation in SDS-PAGE of HSA as a distinct band of about 10 kDa higher than the alpha 1-AT band, which instead maintained the same mobility as in non-reducing conditions. The results indicate that HSA has not been completely removed from alpha 1-AT, and its presence does not affect the electrophoretic mobility of the inhibitor. The possibility that the structural conformation of the alpha 1-AT, rather than contamination with HSA, was responsible for its abnormal slower migratory rate was therefore tested. For this purpose alpha 1-AT preparations of different degrees of purification were submitted to heat treatment to induce a non-inhibitory conformation such as loop-sheet polymerization. Polymerization was followed both by the appearance in SDS- and non-denaturing PAGEs of high molecular weight bands, which were mostly present in less purified preparations of the inhibitor, and by a decrease in inhibitory activity. A higher degree of polymerization with complete loss of inhibitory activity was observed in the unprocessed alpha 1-AT preparation when dissolved in Na-phosphate buffer at acidic pH, and after dialysis. After heat treatment, the purified alpha 1-AT was shown to run faster in the gel and, in both reducing and non-reducing conditions, the calculated mass of the inhibitor was that expected of about 54 kDa. After reducing treatment, high molecular weight polymers in SDS-PAGEs were reduced, strongly suggesting that disulphide bridges are also involved in the polymerization of alpha 1-AT. Results indicate that the mobility of alpha 1-AT in SDS-PAGE is crucially dependent on its structural conformation which dictates the extent of SDS binding. HSA contaminating the alpha 1-AT preparation does not affect the inhibitor conformation although at a higher degree of contamination and in favourable conditions, it does reduce the inhibitor activity.
一种部分纯化的人α1-抗胰蛋白酶(α1-AT)制剂,其作为牛胰蛋白酶抑制剂的活性为60%,被选作起始材料,以研究人血清白蛋白(HSA)的污染性质和程度,并探究这种污染是否是蛋白酶抑制剂在SDS-PAGE中抑制活性降低和迁移速率减慢的原因。免疫印迹分析显示,在未处理的α1-AT制剂中存在HSA,在变性和非变性PAGE中,其迁移率与HSA相同,呈现为一条65 kDa的单带。通过将未处理的α1-AT制剂在Affi-Gel Blue层析柱上进行亲和层析,获得了一种明显高度纯化且均一的α1-AT形式,这通过在非还原条件下测量抑制活性和对SDS-PAGE进行光密度扫描得以证实。然而,免疫印迹分析仍显示从柱上洗脱的抑制剂最活跃部分中存在HSA,并且无论纯化程度如何,抑制剂的分子量始终为65 kDa。用β-巯基乙醇处理后,在SDS-PAGE中HSA分离为一条比α1-AT带高约10 kDa的明显条带,而α1-AT在还原条件下的迁移率与非还原条件下相同。结果表明,HSA尚未从α1-AT中完全去除,其存在不影响抑制剂的电泳迁移率。因此,测试了α1-AT的结构构象而非HSA污染导致其异常缓慢迁移率的可能性。为此,将不同纯化程度的α1-AT制剂进行热处理,以诱导非抑制性构象,如环片聚合。通过在SDS-和非变性PAGE中出现高分子量条带(主要存在于抑制剂纯化程度较低的制剂中)以及抑制活性降低来跟踪聚合过程。当未处理的α1-AT制剂溶解在酸性pH的磷酸钠缓冲液中并透析后,观察到更高程度的聚合且抑制活性完全丧失。热处理后,纯化的α1-AT在凝胶中迁移更快,并且在还原和非还原条件下,计算出的抑制剂分子量约为预期的54 kDa。还原处理后,SDS-PAGE中的高分子量聚合物减少,强烈表明二硫键也参与了α1-AT的聚合。结果表明,α1-AT在SDS-PAGE中的迁移率关键取决于其结构构象,该构象决定了SDS结合的程度。污染α1-AT制剂的HSA不影响抑制剂构象,尽管在更高的污染程度和有利条件下,它确实会降低抑制剂活性。